Analysis of genome and blood components for elucidation and treatment on dementia

Analysis of genome and blood components for elucidation and treatment on dementia - Analysis of genome and blood components for elucidation and treatment on dementia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006146

Enrollment

200

Registered

2011-08-11

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

Antipsychotic agents Antidepressants Chinese herb

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: dementia

Exclusion criteria

Exclusion criteria: severe physical illness

Design outcomes

Primary

Measure	Time frame
Neuropsychiatric Inventory (NPI)	—

Secondary

Measure	Time frame
Mini Mental State Examination (MMSE)	—

Countries

Japan

Contacts

Public ContactMasatake Kurita

Social medical corporation Koutokukai Sato Hospital Department of education and research

kurita@koutoku.or.jp0238-40-3170

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026